These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 7850810
1. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer. Hanski C, Hanski ML, Zimmer T, Ogorek D, Devine P, Riecken EO. Cancer Res; 1995 Feb 15; 55(4):928-33. PubMed ID: 7850810 [Abstract] [Full Text] [Related]
2. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases. Matsushita Y, Cleary KR, Ota DM, Hoff SD, Irimura T. Lab Invest; 1990 Dec 15; 63(6):780-91. PubMed ID: 1979361 [Abstract] [Full Text] [Related]
3. Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression. Hanski C, Drechsler K, Hanisch FG, Sheehan J, Manske M, Ogorek D, Klussmann E, Hanski ML, Blank M, Xing PX. Cancer Res; 1993 Sep 01; 53(17):4082-8. PubMed ID: 7689422 [Abstract] [Full Text] [Related]
4. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope. Baldus SE, Wienand JR, Werner JP, Landsberg S, Drebber U, Hanisch FG, Dienes HP. Int J Oncol; 2005 Nov 01; 27(5):1289-97. PubMed ID: 16211224 [Abstract] [Full Text] [Related]
5. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells. Huang J, Byrd JC, Yoon WH, Kim YS. Oncol Res; 1992 Nov 01; 4(11-12):507-15. PubMed ID: 1284381 [Abstract] [Full Text] [Related]
6. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Kannagi R, Fukushi Y, Tachikawa T, Noda A, Shin S, Shigeta K, Hiraiwa N, Fukuda Y, Inamoto T, Hakomori S. Cancer Res; 1986 May 01; 46(5):2619-26. PubMed ID: 3008996 [Abstract] [Full Text] [Related]
7. Profiles of Lewisx-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma. Singhal AK, Orntoft TF, Nudelman E, Nance S, Schibig L, Stroud MR, Clausen H, Hakomori S. Cancer Res; 1990 Mar 01; 50(5):1375-80. PubMed ID: 2302702 [Abstract] [Full Text] [Related]
8. Increased number of accessible sugar epitopes defined with monoclonal antibody AM-3 on colonic mucins is associated with malignant transformation of colonic mucosa. Hanski C, Sheehan J, Kiehntopf M, Stolze B, Stein H, Riecken EO. Cancer Res; 1991 Oct 01; 51(19):5342-7. PubMed ID: 1717148 [Abstract] [Full Text] [Related]
9. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody. Baeckström D, Nilsson O, Price MR, Lindholm L, Hansson GC. Cancer Res; 1993 Feb 15; 53(4):755-61. PubMed ID: 7679050 [Abstract] [Full Text] [Related]
10. Sialyl Lewis(x) antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence. Hanisch FG, Hanski C, Hasegawa A. Cancer Res; 1992 Jun 01; 52(11):3138-44. PubMed ID: 1350509 [Abstract] [Full Text] [Related]
11. Human colonic sulfomucin identified by a specific monoclonal antibody. Irimura T, Wynn DM, Hager LG, Cleary KR, Ota DM. Cancer Res; 1991 Oct 15; 51(20):5728-35. PubMed ID: 1913691 [Abstract] [Full Text] [Related]
12. Tumor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa. Ogata S, Ho I, Chen A, Dubois D, Maklansky J, Singhal A, Hakomori S, Itzkowitz SH. Cancer Res; 1995 May 01; 55(9):1869-74. PubMed ID: 7537175 [Abstract] [Full Text] [Related]
13. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients. Sakurai Y, Hirohashi S, Shimosato Y, Kodaira S, Abe O. Cancer Res; 1988 Jul 15; 48(14):4053-8. PubMed ID: 2454734 [Abstract] [Full Text] [Related]
14. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin. Ho JJ, Bi N, Yan PS, Yuan M, Norton KA, Kim YS. Cancer Res; 1991 Jan 01; 51(1):372-80. PubMed ID: 1703039 [Abstract] [Full Text] [Related]
15. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain. Kannagi R, Kitahara A, Itai S, Zenita K, Shigeta K, Tachikawa T, Noda A, Hirano H, Abe M, Shin S. Cancer Res; 1988 Jul 01; 48(13):3856-63. PubMed ID: 2454154 [Abstract] [Full Text] [Related]
17. Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: a potential marker of malignant transformation in colon. Robbe-Masselot C, Herrmann A, Maes E, Carlstedt I, Michalski JC, Capon C. J Proteome Res; 2009 Feb 01; 8(2):702-11. PubMed ID: 19152289 [Abstract] [Full Text] [Related]
18. Monoclonal antibody FW6 defines an epitope on alpha 3/4-monofucosylated polylactosaminoglycans expressed by fetal and colon carcinoma-associated mucins. Hanisch FG, Heimbüchel G, Baldus SE, Uhlenbruck G, Schmits R, Pfreundschuh M, Schwonzen M, Vierbuchen M, Bara J, Peter-Katalinic J. Cancer Res; 1993 Sep 15; 53(18):4367-75. PubMed ID: 8364932 [Abstract] [Full Text] [Related]
19. Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastases. Yamori T, Ota DM, Cleary KR, Hoff S, Hager LG, Irimura T. Cancer Res; 1989 Feb 15; 49(4):887-94. PubMed ID: 2912559 [Abstract] [Full Text] [Related]
20. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells. Izumi Y, Taniuchi Y, Tsuji T, Smith CW, Nakamori S, Fidler IJ, Irimura T. Exp Cell Res; 1995 Jan 15; 216(1):215-21. PubMed ID: 7529188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]